ESR1 and breast cancer: Triple‐negative breast cancer (TNBC) is an aggressive breast cancer subtype, which lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER‐2).1